Hemodynamic effects of TX45 , a long-acting Fc-relaxin fusion, in Group 2 pulmonary hypertension patients.

17 May 2025 (16:40 - 16:50)
Organised by: Logo
Congress Presentation Part of: Late-breaking science in heart failure, cardiomyopathies, pulmonary hypertension and valvular heart disease Haemodynamics of Heart Failure HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)